HK$102.10-19.80% · 3M
Moving avg
1W+6.30%
1M+6.52%
3M-17.53%
6M-1.54%
YTD-9.89%
1Y-35.22%
3Y+203.87%
5Y+130.47%
52-week range
$10.2222% of range$22.81
Company health
Value0/6
Growth3/6
Profitability1/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Revenue compounding 219% a year
- Net cash on the balance sheet
Risks
- Currently unprofitable
- Burning free cash flow
Key statistics
Valuation
Market cap
$11.97B
Enterprise value
$9.09B
P/E ratio (TTM)
-67.34x
P/S ratio (TTM)
24.95x
EV/EBITDA
-92.59x
Per share & returns
EPS (TTM)
-$0.15
Dividend yield
0.00%
Beta (1Y)
0.03
30-day change
+6.52%
Trading
Volume (24h)
0
Previous close
HK$101.90
Shares outstanding
919.97M
About Akeso, Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
HKEX
Symbol
9926.HK
Akeso, Inc. is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on HKEX (China) and trade under the ticker 9926.HK.
Frequently asked questions
What is Akeso, Inc.'s market cap?
Akeso, Inc. (9926.HK) has a market capitalization of $11.97B.
What sector is Akeso, Inc. in?
Akeso, Inc. operates in the Healthcare sector, Biotechnology industry.
What exchange does 9926.HK trade on?
9926.HK trades on HKEX.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$358.08B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.55B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.81B cap